Advertisement

The Latest

Cancer patients and oncology clinicians continue to grapple with an ongoing national drug shortage that is now affecting 57 percent of hospital pharmacies, according to an American Society of Health-System Pharmacists poll published Aug. 10. 

An AI-powered machine learning tool may allow physicians to better identify origins in enigmatic cancers, according to researchers at the Massachusetts Institute of Technology in Cambridge, Mass., and Dana-Farber Cancer Institute in Boston. 

Advertisement